| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cbl proto-oncogene like 2 | 0.476 | 0.808 |
|
disease | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2019 | |||||||||
|
Parkinson disease 16 (susceptibility) | 0.861 | 0.077 |
|
disease | 0.400 | None | 0.963 | 27 | 0 | 2009 | 2019 | |||||||||
|
glucosylceramidase beta pseudogene 1 | 0.623 | 0.538 |
|
disease | 0.100 | None | 1.000 | 26 | 1 | 2005 | 2019 | |||||||||
|
cytochrome P450 2D6 | 0.597 | 0.769 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 1994 | 2017 | |||||||||
|
Parkinson disease 10 (susceptibility) | 0.890 | 0.038 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 2005 | 2020 | |||||||||
|
neurofilament light | 0.488 | 0.769 |
|
disease | 0.100 | None | 1.000 | 12 | 0 | 2002 | 2019 | |||||||||
|
Parkinson disease 3 (autosomal dominant, Lewy body) | 0.821 | 0.038 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 1999 | 2013 | |||||||||
|
microRNA 133b | 0.555 | 0.808 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 2007 | 2019 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
disease | 0.100 | None | 1.000 | 8 | 32 | 2009 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 2210 | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 8 | 6 | 2009 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1672 | 0.462 | 0.846 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2006 | 2019 | |||||||||
|
saitohin | 0.705 | 0.385 |
|
disease | 0.160 | None | 1.000 | 7 | 3 | 2003 | 2015 | |||||||||
|
MAPT antisense RNA 1 | 0.711 | 0.269 |
|
disease | 0.120 | None | 1.000 | 6 | 32 | 2009 | 2019 | |||||||||
|
microRNA 221 | 0.449 | 0.846 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2013 | 2020 | |||||||||
|
microRNA 34b | 0.509 | 0.808 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2011 | 2017 | |||||||||
|
POTE ankyrin domain family member K, pseudogene | 0.542 | 0.769 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1997 | 2002 | |||||||||
|
cytochrome c oxidase subunit II | 0.352 | 0.962 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2000 | 2018 | |||||||||
|
microRNA 433 | 0.604 | 0.538 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2008 | 2018 | |||||||||
|
PPP1R2C family member C | 0.478 | 0.846 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2005 | 2019 | |||||||||
|
CCNT2 antisense RNA 1 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 4 | 2 | 2011 | 2017 | |||||||||
|
microRNA 4697 | 0.931 | 0.077 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2018 | |||||||||
|
LRRK2 divergent transcript | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 4 | 6 | 2012 | 2017 | |||||||||
|
cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene) | 0.659 | 0.577 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 1998 | 2016 | |||||||||
|
DnaJ heat shock protein family (Hsp40) member B1 pseudogene 1 | 0.650 | 0.654 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2018 | |||||||||
|
Restless legs syndrome, susceptibility to | 0.705 | 0.423 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2015 | 2019 |